Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section updated with new sites (Alabama, California, Florida, Nebraska, Ohio, Tennessee, Wisconsin, and Quebec) and removal of existing sites. Revision: v3.3.3.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a 'Last Update Posted (Estimated)' field and a 'Revision: v3.3.2' label, while the previous 'Last Update Posted' and 'Revision: v3.3.1' labels were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedLocation information updated: the study now lists 86 locations and several sites were removed (Dnipro, Madrid, Porto, Loures, Lisbon). A PubMed-derived publications note and a new revision (v3.3.1) were also added.SummaryDifference0.5%

- Check48 days agoChange DetectedRemoved a site-wide notice about government funding lapses, which does not affect the trial's core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe updates appear to be cosmetic, with only formatting/layout adjustments to the Study Details page and no changes to core trial content such as design, eligibility criteria, interventions, primary/secondary outcomes, or listed sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdate: revision number upgraded from v3.0.2 to v3.2.0, indicating a new release. No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.